ArticleBMJ open2026

Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis.

Binquan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.